Jillian J. Kril

ORCID: 0000-0001-9407-8674
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Amyotrophic Lateral Sclerosis Research
  • Alcoholism and Thiamine Deficiency
  • Parkinson's Disease Mechanisms and Treatments
  • Dementia and Cognitive Impairment Research
  • Neurological and metabolic disorders
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroscience and Neuropharmacology Research
  • Neurological diseases and metabolism
  • Alcohol Consumption and Health Effects
  • Advanced Neuroimaging Techniques and Applications
  • Infectious Encephalopathies and Encephalitis
  • Memory and Neural Mechanisms
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Functional Brain Connectivity Studies
  • Neurogenetic and Muscular Disorders Research
  • Cholinesterase and Neurodegenerative Diseases
  • S100 Proteins and Annexins
  • Neurological Disease Mechanisms and Treatments
  • Neurobiology of Language and Bilingualism
  • Diet and metabolism studies
  • Neurological disorders and treatments
  • Prion Diseases and Protein Misfolding
  • Prenatal Substance Exposure Effects
  • Peroxisome Proliferator-Activated Receptors

The University of Sydney
2015-2024

Macquarie University
2021-2024

UNSW Sydney
2003-2019

Neuroscience Research Australia
1997-2019

Royal Prince Alfred Hospital
1990-2019

Garvan Institute of Medical Research
2019

St Vincent's Clinic
2016-2019

ARC Centre of Excellence in Cognition and its Disorders
2019

Sahlgrenska University Hospital
2017

University of Ottawa
2017

The term frontotemporal dementia (FTD) encompasses a range of clinical syndromes that are believed not to map reliably onto the spectrum recognized pathologies. This study reexamines relationships between and pathological subtypes FTD in large series from two centers (n = 61). Clinical defined were behavioral variant 26), language variants (semantic dementia, n 9; progressive nonfluent aphasia, 8), motor (corticobasal degeneration, neuron disease, 9), although most cases presented with...

10.1002/ana.20203 article EN Annals of Neurology 2004-08-10
Vivianna M. Van Deerlin Patrick Sleiman Maria Martinez‐Lage Alice Chen‐Plotkin Li-San Wang and 95 more Neill R. Graff‐Radford Dennis W. Dickson Rosa Rademakers Bradley F. Boeve Murray Grossman Steven E. Arnold David Mann Stuart Pickering‐Brown Harro Seelaar Peter Heutink John C. van Swieten Jill R. Murrell Bernardino Ghetti Salvatore Spina Jordan Grafman John R. Hodges Maria Grazia Spillantini Sid Gilman Andrew P. Lieberman Jeffrey Kaye Randall L. Woltjer Eileen H. Bigio Marsel Mesulam Safa Al‐Sarraj Claire Troakes Roger N. Rosenberg Charles L. White Isidró Ferrer Albert Lladó Manuela Neumann Hans A. Kretzschmar Christine M. Hulette Kathleen A. Welsh‐Bohmer Bruce L. Miller Ainhoa Alzualde Adolfo López de Munain Ann C. McKee Marla Gearing Allan I. Levey James J. Lah John Hardy Jonathan D. Rohrer Tammaryn Lashley Ian R. Mackenzie Howard Feldman Ronald L. Hamilton Steven T. DeKosky Julie van der Zee Samir Kumar‐Singh Christine Van Broeckhoven Richard Mayeux Jean Paul Vonsattel Juan C. Troncoso Jillian J. Kril John B. Kwok Glenda M. Halliday Thomas D. Bird Paul G. Ince Pamela J. Shaw Nigel J. Cairns John C. Morris Catriona McLean Charles DeCarli William G. Ellis Stefanie H. Freeman Matthew P. Frosch John H. Growdon Daniel P. Perl Mary Sano David A. Bennett Julie A. Schneider Thomas G. Beach Eric M. Reiman Bryan K. Woodruff Jeffrey L. Cummings Harry V. Vinters Carol A. Miller Helena C. Chui Irina Alafuzoff Päivi Hartikainen Danielle Seilhean Douglas Galasko Eliezer Masliah Carl W. Cotman MJ Tuñón Mònica Martínez David G. Muñoz Steven L. Carroll Daniel Marson Peter Riederer Nenad Bogdanović Daniela Berg Håkon Håkonarson John Q. Trojanowski Virginia M.‐Y. Lee

10.1038/ng.536 article EN Nature Genetics 2010-02-14

To establish better operational criteria for the diagnosis of Wernicke's encephalopathy. Current diagnosing encephalopathy require presence three clinical signs (oculomotor abnormalities, cerebellar dysfunction, and an altered mental state), although it has often been reported that most patients do not fulfil all these criteria.The histories 28 alcoholics with neurological neuropsychological assessments definitive neuropathological diagnoses were examined to determine use in a screening...

10.1136/jnnp.62.1.51 article EN Journal of Neurology Neurosurgery & Psychiatry 1997-01-01

To establish survival in patients with pathologically confirmed frontotemporal dementia (FTD) and to determine whether clinical or pathologic subtype affects prognosis.The authors reviewed the presenting features of 61 FTD studied Sydney (n = 31) Cambridge 30) over a 10-year period. Data were available on time symptom onset, diagnosis, institutionalization, death. Cases classified as tau-positive tau-negative.Of FTD, 26 presented frontal variant (fvFTD), 9 semantic dementia, 8 progressive...

10.1212/01.wnl.0000078928.20107.52 article EN Neurology 2003-08-12

<b>Objective: </b> White matter hyperintensities (WMH) are commonly seen on neuroimaging scans, but their underlying histopathologic substrate is unclear. The aim of this work was to establish the pathologic correlates WMH in unselected elderly cases using two study designs. To avoid potential bias from comparisons different anatomic regions, 1 compared, region-by-region, severity determined vivo with measures each major white (WM) components. Study 2 compared histopathology normal WM....

10.1212/01.wnl.0000319691.50117.54 article EN Neurology 2008-08-07
Olivia Anna Skrobot Sandra E. Black Christopher Chen Charles DeCarli Timo Erkinjuntti and 95 more Gary A. Ford Raj N. Kalaria John T. O’Brien Leonardo Pantoni Florence Pasquier Gustavo C. Román Anders Wallin Perminder S. Sachdev Ingmar Skoog Fernando E. Taragano Jillian J. Kril Margherita Cavalieri K. A. Jellinger Gábor G. Kovács S. Engelborghs C. Lafosse Paulo Henrique Ferreira Bertolucci Sônia Maria Dozzi Brucki Paulo Caramelli Tania C. T. Ferraz Alves Christian Bocti Tamás Fülöp David B. Hogan Ging‐Yuek Robin Hsiung Andrew Kirk Lopa Leach A. Robillard Demetrios J. Sahlas Qihao Guo Jiang Tian Laura Hokkanen Hanna Jokinen Sarah Benisty Vincent Deramecourt Jean‐Jacques Hauw H. Lenoir Marianna Tsatali Magda Tsolaki Uma Sundar Robert F. Coen Amos D. Korczyn M. Altieri Marzia Baldereschi C. Caltagirone G. Caravaglios Antonio Di Carlo Vittorio Di Piero Guido Gainotti Samantha Galluzzi Giancarlo Logroscino Patrizia Mecocci Davide Vito Moretti Alessandro Padovani Toshiya Fukui Masafumi Ihara Toshiki Mizuno Soo Young Kim Rufus Akinyemi Olusegun Baiyewu Adesola Ogunniyi A. Szczudlik António J. Bastos‐Leite Horácio Firmino João Massano Ana Verdelho L. S. Kruglov M. Kamran Ikram Nagaendran Kandiah Estanislao Arana José Barroso T Calatayud Alfonso J. Cruz‐Jentoft Secundino López‐Pousa Pablo Martínez‐Lage María Mataró Anne Börjesson‐Hanson Elisabet Englund Erika J. Laukka Cheng-Wei Qiu Matti Viitanen Geert Jan Biessels F.‐E. de Leeuw Tom den Heijer Lieza G. Exalto L. Jaap Kappelle Niels D. Prins Edo Richard Ben Schmand Esther van den Berg Wiesje M. van der Flier Başar Bılgıç Louise Allan Judy Archer Johannes Attems Antony Bayer

Abstract Introduction Progress in understanding and management of vascular cognitive impairment (VCI) has been hampered by lack consensus on diagnosis, reflecting the use multiple different assessment protocols. A large multinational group clinicians researchers participated a two‐phase Vascular Impairment Cognition Classification Consensus Study (VICCCS) to agree principles (VICCCS‐1) protocols (VICCCS‐2) for diagnosis VCI. We present VICCCS‐2. Methods used VICCCS‐1 published diagnostic...

10.1016/j.jalz.2017.09.007 article EN Alzheimer s & Dementia 2017-10-19

Alzheimer's disease (AD) brains are characterized by amyloid-β-containing plaques and hyperphosphorylated tau-containing neurofibrillary tangles (NFTs); however, in frontotemporal dementia, the tau pathology manifests absence of overt amyloid-β plaques. Therapeutic strategies so far have primarily been targeting amyloid-β, although those only slowly beginning to emerge. Here, we identify sodium selenate as a compound that reduces phosphorylation both vitro vivo. Importantly, chronic oral...

10.1073/pnas.1009038107 article EN Proceedings of the National Academy of Sciences 2010-07-19

Amyloid-β (Aβ) toxicity in Alzheimer's disease (AD) is considered to be mediated by phosphorylated tau protein. In contrast, we found that, at least early disease, site-specific phosphorylation of inhibited Aβ toxicity. This specific was the neuronal p38 mitogen-activated protein kinase p38γ and interfered with postsynaptic excitotoxic signaling complexes engaged Aβ. Accordingly, depletion exacerbated circuit aberrations, cognitive deficits, premature lethality a mouse model AD, whereas...

10.1126/science.aah6205 article EN Science 2016-11-17

Neurogenesis in the postnatal human brain occurs two neurogenic niches; subventricular zone (SVZ) wall of lateral ventricles and subgranular (SGZ) hippocampus. The extent to which this physiological process continues into adulthood is an area ongoing research. This study aimed characterize markers cell proliferation assess efficacy antibodies used identify neurogenesis both niches brain.

10.1111/nan.12337 article EN Neuropathology and Applied Neurobiology 2016-07-18

<h3>Objective</h3> To assess the impact of new clinical diagnostic criteria for frontotemporal dementia (FTD) syndromes, including primary progressive aphasias (PPA), on prior diagnosis and to explore clinicopathological correlations. <h3>Methods</h3> 178 consecutive neuropathologically ascertained cases initially diagnosed with a FTD syndrome were collected through specialist programmes: Cambridge Brain Bank, UK, Sydney Australia. 135 reclassified using revised into behavioural variant...

10.1136/jnnp-2013-306948 article EN Journal of Neurology Neurosurgery & Psychiatry 2014-01-13
Olivia Anna Skrobot John T. O’Brien Sandra E. Black Christopher Chen Charles DeCarli and 95 more Timo Erkinjuntti Gary A. Ford Raj N. Kalaria Leonardo Pantoni Florence Pasquier Gustavo C. Román Anders Wallin Perminder S. Sachdev Ingmar Skoog Fernando E. Taragano Jillian J. Kril Margherita Cavalieri K. A. Jellinger Gábor G. Kovács S. Engelborghs C. Lafosse Paulo Henrique Ferreira Bertolucci Sônia Maria Dozzi Brucki Paulo Caramelli Tania C. T. Ferraz Alves Christian Bocti Tamàs Fülöp David B. Hogan Ging‐Yuek Robin Hsiung Andrew Kirk Lopa Leach A. Robillard Demetrios J. Sahlas Qihao Guo Jiang Tian Laura Hokkanen Hanna Jokinen Sarah Benisty Vincent Deramecourt Jean‐Jacques Hauw H. Lenoir Marianna Tsatali Magda Tsolaki Uma Sundar Robert F. Coen Amos D. Korczyn M. Altieri Marzia Baldereschi C. Caltagirone G. Caravaglios Antonio Di Carlo Vittorio Di Piero Guido Gainotti Samantha Galluzzi Giancarlo Logroscino Patrizia Mecocci Davide Vito Moretti Alessandro Padovani Toshiya Fukui Masafumi Ihara Toshiki Mizuno Sooyoung Kim Rufus Akinyemi Olusegun Baiyewu Adesola Ogunniyi A. Szczudlik António J. Bastos‐Leite Horácio Firmino João Massano Ana Verdelho L. S. Kruglov M. Kamran Ikram Nagaendran Kandiah Estanislao Arana José Barroso T Calatayud Alfonso J. Cruz‐Jentoft Secundino López‐Pousa Pablo Martínez‐Lage María Mataró Anne Börjesson‐Hanson Elisabet Englund Erika J. Laukka Cheng-Wei Qiu Matti Viitanen Geert Jan Biessels F.‐E. de Leeuw Tom den Heijer Lieza G. Exalto L. Jaap Kappelle Niels D. Prins Edo Richard Ben Schmand Esther van den Berg Wiesje M. van der Flier Başar Bılgıç Louise Allan Judy Archer Johannes Attems Antony Bayer

Abstract Introduction Numerous diagnostic criteria have tried to tackle the variability in clinical manifestations and problematic diagnosis of vascular cognitive impairment (VCI) but none been universally accepted. These not readily comparable, impacting on rates turn prevalence estimates, research, treatment. Methods The Vascular Impairment Cognition Classification Consensus Study (VICCCS) involved participants (81% academic researchers) from 27 countries an online Delphi consensus study....

10.1016/j.jalz.2016.10.007 article EN Alzheimer s & Dementia 2016-12-10

Semantic dementia is a syndrome of progressive deterioration in semantic memory (knowledge objects, people, concepts and words). It falls within the clinical spectrum frontotemporal but its pathology yet to be studied systematically. This study included 18 consecutive post mortem cases meeting criteria for dementia. Clinic records diagnostic histopathology were available all cases; structural neuroimaging, neuropsychology semi-quantitative histopathology/immunohistochemistry data analysed...

10.1093/brain/awh582 article EN Brain 2005-07-06

Many studies have demonstrated significant sexual dimorphism in verbal ability. However, few examined anatomical differences between the sexes that may underlie such dimorphism.To examine sex absolute and proportional volumes of main language-associated regions cerebral cortex.Control neuropathological case series consecutive autopsies from a teaching hospital. No age-related volume changes were identified sample. Two cortical regions, superior temporal gyrus (part Wernicke area) its...

10.1001/archneur.1997.00550140045011 article EN Archives of Neurology 1997-02-01

To devise a staging scheme for addressing the severity of atrophy in patients with pathologically proven frontotemporal dementia (FTD) and determine any relationship clinical indices.Twenty-four cases pathologic features FTD were selected using standard inclusion exclusion criteria from 125 collected Sydney, Australia, over an 8.5-year period. Patterns gross determined two coronal brain slices. Reproducibility four-stage was tested. Nonparametric statistics used to relationships between...

10.1212/01.wnl.0000052685.09194.39 article EN Neurology 2003-03-25

Abstract Maps of cytoarchitectonically defined cortical areas have proven to be a valuable tool for anatomic localization activated brain regions revealed by functional imaging studies. However, architectonic data require observations in sample postmortem brains. They can only used reliably comparison with as probabilistic maps after spatial normalization common reference space. The complete analysis an individual living has not been achievable date, because the relationship remains unclear...

10.1002/hbm.20082 article EN Human Brain Mapping 2004-11-12

Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-43)-negative frontotemporal lobar degeneration (FTLD) cases, present here the first comprehensive analysis of these cases in terms neuropathology, genetics, demographics clinical data. 92% (34/37) had fused sarcoma (FUS) pathology, indicating that FTLD-FUS is important FTLD subtype. This collection specifically focussed on aFTLD-U one three recently defined subtypes FTLD-FUS. The subtype...

10.1007/s00401-010-0698-6 article EN cc-by-nc Acta Neuropathologica 2010-05-19
Coming Soon ...